Mayo Stephen — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Mayo Stephen has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $123K.

Profile

Stephen Mayo is a prominent figure in the biotechnology sector, known for his role at Sarepta Therapeutics, Inc., a company focused on developing innovative therapies for rare diseases, particularly those related to muscular dystrophy. He has contributed to the strategic direction and scientific advancements of the company.

Board memberships

• Sarepta Therapeutics, Inc.

Awards & honors

• Leadership in developing therapies for Duchenne muscular dystrophy
• Contributions to biotechnology research and innovation

Recent Transactions

Companies — Last 90 Days

• Allogene Therapeutics, Inc. (ALLO) — 1 filings, last 2026-06-23
• Sarepta Therapeutics, Inc. (SRPT) — 1 filings, last 2026-06-06
• Merck & Co., Inc. (MRK) — 1 filings, last 2026-06-02

Frequently Asked Questions

Who is Mayo Stephen?

Stephen Mayo is a prominent figure in the biotechnology sector, known for his role at Sarepta Therapeutics, Inc., a company focused on developing innovative therapies for rare diseases, particularly those related to muscular dystrophy. He has contributed to the strategic direction and scientific advancements of the company.…

How many SEC Form 4 filings has Mayo Stephen submitted recently?

3 primary Form 4 filings in the last 90 days, covering 3 companies.

Has Mayo Stephen been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($123K) across all tracked filings.

Where can I see all of Mayo Stephen's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week